Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 13 studies | 27% ± 12% | |
non-classical monocyte | 10 studies | 36% ± 17% | |
retinal rod cell | 6 studies | 28% ± 13% | |
monocyte | 5 studies | 32% ± 19% | |
conventional dendritic cell | 4 studies | 47% ± 19% | |
dendritic cell | 4 studies | 50% ± 21% | |
retinal bipolar neuron | 3 studies | 39% ± 7% | |
endothelial cell | 3 studies | 21% ± 2% | |
retinal cone cell | 3 studies | 56% ± 15% | |
rod bipolar cell | 3 studies | 44% ± 19% | |
macrophage | 3 studies | 41% ± 24% | |
natural killer cell | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 2260.94 | 328 / 328 | 100% | 52.32 | 178 / 178 |
skin | 100% | 3993.36 | 1808 / 1809 | 100% | 101.02 | 472 / 472 |
prostate | 100% | 4199.70 | 245 / 245 | 99% | 84.11 | 499 / 502 |
intestine | 100% | 3113.21 | 964 / 966 | 99% | 86.17 | 524 / 527 |
breast | 100% | 5482.51 | 459 / 459 | 99% | 84.41 | 1109 / 1118 |
lung | 100% | 4660.07 | 577 / 578 | 99% | 75.92 | 1145 / 1155 |
stomach | 100% | 4980.24 | 359 / 359 | 99% | 72.48 | 283 / 286 |
esophagus | 100% | 3349.93 | 1445 / 1445 | 99% | 70.96 | 181 / 183 |
ovary | 100% | 3009.14 | 180 / 180 | 99% | 41.17 | 425 / 430 |
uterus | 100% | 2467.04 | 170 / 170 | 98% | 62.49 | 452 / 459 |
bladder | 100% | 3967.81 | 21 / 21 | 97% | 74.43 | 490 / 504 |
brain | 95% | 2115.43 | 2513 / 2642 | 99% | 32.63 | 697 / 705 |
thymus | 99% | 1825.47 | 648 / 653 | 94% | 22.70 | 571 / 605 |
kidney | 99% | 2037.76 | 88 / 89 | 82% | 23.01 | 741 / 901 |
adrenal gland | 100% | 2045.45 | 257 / 258 | 55% | 22.05 | 127 / 230 |
adipose | 100% | 6209.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 44.61 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 107.55 | 29 / 29 |
spleen | 100% | 7637.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 55.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.84 | 1 / 1 |
peripheral blood | 100% | 17936.92 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2594.59 | 1323 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 1608.85 | 829 / 861 | 0% | 0 | 0 / 0 |
liver | 19% | 210.15 | 43 / 226 | 32% | 10.83 | 129 / 406 |
muscle | 12% | 115.32 | 98 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006183 | Biological process | GTP biosynthetic process |
GO_0006177 | Biological process | GMP biosynthetic process |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003938 | Molecular function | IMP dehydrogenase activity |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0000166 | Molecular function | nucleotide binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | IMPDH1 |
Protein name | Inosine-5'-monophosphate dehydrogenase (EC 1.1.1.205) Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I) Inosine monophosphate dehydrogenase 1 Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205) |
Synonyms | IMPDH IMPD1 |
Description | FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. . |
Accessions | A0A3B3IRL5 C9K0R9 C9J029 ENST00000473463.1 P20839 ENST00000354269.9 [P20839-5] F8WDE9 ENST00000480861.5 [P20839-4] ENST00000348127.11 [P20839-3] ENST00000338791.11 [P20839-6] ENST00000469328.5 ENST00000489263.1 ENST00000419067.6 [P20839-7] ENST00000470772.5 C9J381 ENST00000648462.1 H7C5T1 ENST00000496200.5 [P20839-2] ENST00000497868.5 |